Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas

Xiao Ping Li, Zheng Chen, Zhiqiang Meng, Wen Xia Huang, Luming Liu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim: The association has been established between the disorder of carbohydrate metabolism and liver cancer. However, little is known regarding the impact of concurrent hyperglycemia on prognosis of hepatocellular carcinoma (HCC). The present study aimed at solving this problem. Methods: A total of 225 patients included in this study, were admitted from January 1998 to December 2001 for an unresectable HCC proven by histological and imaging examinations. Most of the patients received interventional treatment, radiation and biotherapy. Response was evaluated by computerized tomography (CT) scan conducted 4-6 weeks following completion of the treatment, and then every 3 months. Survival was calculated from the beginning of treatment using the Kaplan-Meier method. Pretreatment, treatment and follow-up variables with possible prognostic significance were analyzed. A stepwise multivariate analysis was performed using the Cox regression model, and a prognostic index was obtained. Results: No differences were observed in survival parameters between the patients with and without hyperglycemia, median survival times of the patients were being 26±3.46 months and 29.5±2.04 months, respectively, and the 3-year survival rate was 8.36 % and 9.62 %, respectively. The univariate analysis indicated that there were several survival-associated variables including serum AFP level, clinical stage, Child-Pugh grade, method of treatment, size and number of tumor nodule (s). However, only the clinical stage, Child-Pugh grade and the treatment procedure were proved to be independent prognostic factors in the multivariate analysis. Conclusion: This study indicates that hyperglycemia does not influence the long-term prognosis of HCC, and concurrent hyperglycemia should not be considered as an unfavorable prognostic factor during the treatment of patients with HCC.

Original languageEnglish (US)
Pages (from-to)1848-1852
Number of pages5
JournalWorld journal of gastroenterology
Volume9
Issue number8
DOIs
StatePublished - Aug 15 2003

Fingerprint

Hyperglycemia
Hepatocellular Carcinoma
Survival
Therapeutics
Multivariate Analysis
Biological Therapy
Carbohydrate Metabolism
Liver Neoplasms
Proportional Hazards Models
Survival Rate
Tomography
Radiation
Serum
Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas. / Li, Xiao Ping; Chen, Zheng; Meng, Zhiqiang; Huang, Wen Xia; Liu, Luming.

In: World journal of gastroenterology, Vol. 9, No. 8, 15.08.2003, p. 1848-1852.

Research output: Contribution to journalArticle

@article{d6b6537611ef42deb5cc9f6d90f24e72,
title = "Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas",
abstract = "Aim: The association has been established between the disorder of carbohydrate metabolism and liver cancer. However, little is known regarding the impact of concurrent hyperglycemia on prognosis of hepatocellular carcinoma (HCC). The present study aimed at solving this problem. Methods: A total of 225 patients included in this study, were admitted from January 1998 to December 2001 for an unresectable HCC proven by histological and imaging examinations. Most of the patients received interventional treatment, radiation and biotherapy. Response was evaluated by computerized tomography (CT) scan conducted 4-6 weeks following completion of the treatment, and then every 3 months. Survival was calculated from the beginning of treatment using the Kaplan-Meier method. Pretreatment, treatment and follow-up variables with possible prognostic significance were analyzed. A stepwise multivariate analysis was performed using the Cox regression model, and a prognostic index was obtained. Results: No differences were observed in survival parameters between the patients with and without hyperglycemia, median survival times of the patients were being 26±3.46 months and 29.5±2.04 months, respectively, and the 3-year survival rate was 8.36 {\%} and 9.62 {\%}, respectively. The univariate analysis indicated that there were several survival-associated variables including serum AFP level, clinical stage, Child-Pugh grade, method of treatment, size and number of tumor nodule (s). However, only the clinical stage, Child-Pugh grade and the treatment procedure were proved to be independent prognostic factors in the multivariate analysis. Conclusion: This study indicates that hyperglycemia does not influence the long-term prognosis of HCC, and concurrent hyperglycemia should not be considered as an unfavorable prognostic factor during the treatment of patients with HCC.",
author = "Li, {Xiao Ping} and Zheng Chen and Zhiqiang Meng and Huang, {Wen Xia} and Luming Liu",
year = "2003",
month = "8",
day = "15",
doi = "10.3748/wjg.v9.i8.1848",
language = "English (US)",
volume = "9",
pages = "1848--1852",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "8",

}

TY - JOUR

T1 - Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas

AU - Li, Xiao Ping

AU - Chen, Zheng

AU - Meng, Zhiqiang

AU - Huang, Wen Xia

AU - Liu, Luming

PY - 2003/8/15

Y1 - 2003/8/15

N2 - Aim: The association has been established between the disorder of carbohydrate metabolism and liver cancer. However, little is known regarding the impact of concurrent hyperglycemia on prognosis of hepatocellular carcinoma (HCC). The present study aimed at solving this problem. Methods: A total of 225 patients included in this study, were admitted from January 1998 to December 2001 for an unresectable HCC proven by histological and imaging examinations. Most of the patients received interventional treatment, radiation and biotherapy. Response was evaluated by computerized tomography (CT) scan conducted 4-6 weeks following completion of the treatment, and then every 3 months. Survival was calculated from the beginning of treatment using the Kaplan-Meier method. Pretreatment, treatment and follow-up variables with possible prognostic significance were analyzed. A stepwise multivariate analysis was performed using the Cox regression model, and a prognostic index was obtained. Results: No differences were observed in survival parameters between the patients with and without hyperglycemia, median survival times of the patients were being 26±3.46 months and 29.5±2.04 months, respectively, and the 3-year survival rate was 8.36 % and 9.62 %, respectively. The univariate analysis indicated that there were several survival-associated variables including serum AFP level, clinical stage, Child-Pugh grade, method of treatment, size and number of tumor nodule (s). However, only the clinical stage, Child-Pugh grade and the treatment procedure were proved to be independent prognostic factors in the multivariate analysis. Conclusion: This study indicates that hyperglycemia does not influence the long-term prognosis of HCC, and concurrent hyperglycemia should not be considered as an unfavorable prognostic factor during the treatment of patients with HCC.

AB - Aim: The association has been established between the disorder of carbohydrate metabolism and liver cancer. However, little is known regarding the impact of concurrent hyperglycemia on prognosis of hepatocellular carcinoma (HCC). The present study aimed at solving this problem. Methods: A total of 225 patients included in this study, were admitted from January 1998 to December 2001 for an unresectable HCC proven by histological and imaging examinations. Most of the patients received interventional treatment, radiation and biotherapy. Response was evaluated by computerized tomography (CT) scan conducted 4-6 weeks following completion of the treatment, and then every 3 months. Survival was calculated from the beginning of treatment using the Kaplan-Meier method. Pretreatment, treatment and follow-up variables with possible prognostic significance were analyzed. A stepwise multivariate analysis was performed using the Cox regression model, and a prognostic index was obtained. Results: No differences were observed in survival parameters between the patients with and without hyperglycemia, median survival times of the patients were being 26±3.46 months and 29.5±2.04 months, respectively, and the 3-year survival rate was 8.36 % and 9.62 %, respectively. The univariate analysis indicated that there were several survival-associated variables including serum AFP level, clinical stage, Child-Pugh grade, method of treatment, size and number of tumor nodule (s). However, only the clinical stage, Child-Pugh grade and the treatment procedure were proved to be independent prognostic factors in the multivariate analysis. Conclusion: This study indicates that hyperglycemia does not influence the long-term prognosis of HCC, and concurrent hyperglycemia should not be considered as an unfavorable prognostic factor during the treatment of patients with HCC.

UR - http://www.scopus.com/inward/record.url?scp=0042427786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042427786&partnerID=8YFLogxK

U2 - 10.3748/wjg.v9.i8.1848

DO - 10.3748/wjg.v9.i8.1848

M3 - Article

C2 - 12918136

AN - SCOPUS:0042427786

VL - 9

SP - 1848

EP - 1852

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 8

ER -